0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinicopathologic Report |

Mycobacterium chelonae Conjunctivitis and Scleritis Following Vitrectomy FREE

Curtis E. Margo, MD, MPH; Peter Reed Pavan, MD
[+] Author Affiliations

Section Editor: W. Richard Green, MD
From the Departments of Ophthalmology, Watson Clinic, Lakeland, (Dr Margo) and University of South Florida, Tampa (Dr Pavan).

More Author Information
Arch Ophthalmol. 2000;118(8):1125-1128. doi:10.1001/archopht.118.8.1125.
Text Size: A A A
Published online

The atypical, or nontuberculous, mycobacteria are opportunistic pathogens that usually cause infection following accidental trauma or surgery. These organisms are ubiquitous in nature but have been found with increasing frequency in other environments that include medical offices and surgical suites. Management of atypical mycobacterial ocular infections can be difficult because in vitro antibiotic activity does not always correlate with in vivo efficacy and because normal immune defenses against mycobacteria may work too slowly to prevent irreversible damage to infected ocular tissues. This report describes a patient who developed a severe ocular infection due to Mycobacterium chelonae after vitrectomy. Despite eradication of the infection, the eye became blind and painful.

Figures in this Article

Atypical, or nontuberculous, mycobacteria are widely distributed in nature and have been generally regarded as acid-fast saprophytes.1 Although most atypical mycobacteria display low human pathogenicity, serious human infections have been associated with accidental and surgical trauma.217 This report describes a severe ocular infection caused by Mycobacterium chelonae that occurred after an uncomplicated vitrectomy.

A 67-year-old man was referred for evaluation of a left idiopathic epiretinal membrane. Eight years earlier, the patient underwent a left cataract extraction with placement of a posterior chamber intraocular lens. He began treatment for open-angle glaucoma several years later with topical 2% pilocarpine hydrochloride and 0.5% timolol maleate in both eyes. Eight months earlier the patient was diagnosed as having a squamous cell carcinoma of the left upper eyelid and subsequently completed a course of external beam radiation (56 Gy; 20 sessions). One month after radiation treatment, a fibrinoid exudate developed along the left upper eyelid margin that was treated with oral prednisone and cephalexin for several weeks. The left conjunctiva remained persistently red and irritated.

Over the next 6 months the patient was treated for this irritation with combinations of artificial tears, punctal plugs, topical corticosteroids, topical nonsteroidal anti-inflammatory medications, topical antibiotics, vitamin A ointment, oral doxycycline, and a bandage contact lens with improvement in comfort and decrease in left conjunctival hyperemia.

When the patient was referred for evaluation of his epiretinal membrane, corrected visual acuity was 20/25 OD and 20/60 OS. Vitrectomy with removal of the epiretinal membrane was performed without complication. A culture of the vitreous was obtained during surgery as part of a study to determine the rate of positive vitreous cultures in eyes without signs of inflammation or infection.18 Five days after surgery, 18 colonies of a rapidly growing mycobacterium were reported (later identified as Mycobacterium chelonae). Four weeks after surgery, the eye was mildly inflamed and there were focal lesions around the polyglactin 910 (Vicryl) sutures at the scleral vitrectomy ports. Conjunctival cultures yielded coagulase-negative Staphylococcus and a rapidly growing mycobacterium (later identified as M chelonae). Several weeks later, the focal conjunctival lesions had enlarged (Figure 1). The specimen retrieved during biopsy of the conjunctiva at the superotemporal vitrectomy port was sent for culture and pathologic examination. The biopsy specimen showed large numbers of acid-fast organisms (see below); the culture was positive after 4 days for a rapidly growing species of mycobacterium (later identified as M chelonae).

Place holder to copy figure label and caption
Figure 1.

Left, A 3 × 6-mm scleral defect is present in the left eye between the 2- and 4-o'clock positions just posterior to the limbus at the site of a previous vitrectomy port. The area of scleral thinning is surrounded by intensely hyperemic conjunctiva and sclera. The cornea is transparent at this time. Right, A similar but more circular area of scleral thinning is present at the second vitrectomy port site at the 10-o'clock position. No discharge is present.

Graphic Jump Location

Later that week, dural patch grafts were sewn into place over thinning sclera at the vitrectomy port sites. A Hessburg lavage was inserted through the upper eyelid and the eye was bathed continuously for 29 days with amikacin sulfate (50 mg/mL). The patient was also treated with intravenous amikacin (29 days), vancomycin hydrochloride (10 days), imipenem–cilastatin sodium (Primaxin) (28 days), oral ciprofloxocan hydrochloride (28 days), and oral clarithromycin (28 days). Intravenous morphine sulfate was used for pain. The 2 dural patch grafts melted and were replaced after several weeks. Conjunctival cultures taken during regrafting surgery, nearly 3 weeks after antibiotic therapy had been started, were negative for organisms. In vitro sensitivities from the first 2 culture yields were not available to guide initial therapy, but they eventually showed the organism sensitive to kanamycin, amikacin, and clarithromycin only. The patient was discharged from the hospital after 5 weeks on a regimen of topical amikacin sulfate (50 mg/mL), and oral ciprofloxocin and clarithromycin.

Following discharge from the hospital, ocular pain increased. Vision in the left eye declined to light perception; the eye was enucleated 15 weeks after vitrectomy.

The initial conjunctival biopsy specimen at the vitrectomy port site showed acute and chronic inflammation and focal granuloma formation (Figure 2). A large number of intracellular weakly acid-fast organisms were identified with the Ziehl-Neelsen stain (Figure 3). Conjunctival biopsy specimens taken when the initial scleral patch grafts were replaced showed mixed acute and chronic inflammation and granulation tissue. Only a few acid-fast organisms were identified with special stains.

Place holder to copy figure label and caption
Figure 2.

Results of a left conjunctival biopsy adjacent to the area of scleral thinning shows a mixture of chronic inflammatory cells. Numerous lymphocytes are dispersed among clusters of paler-staining epithelioid cells (asterisk) (hematoxylin-eosin, original magnification × 60).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Acid-fast stain of conjunctival biopsy specimen shows an acid-fast positive rod within epithelioid histiocyte, center of photograph (Ziehl-Neelsen, original magnification × 410).

Graphic Jump Location

The enucleated left eye had an opaque, white cornea and 2 large episcleral grafts held in place with monofilament suture from the 1- to 5-o'clock positions and the 7- to 10-o'clock positions. The cornea showed extensive stromal necrosis and chronic inflammation. The sclera over the ciliary body and anterior choroid was thin and in some foci less than one fifth the normal thickness. Ectatic sclera was covered by patch grafts. The graft-host interface contained chronic inflammatory cells and granulation tissue. Lymphocytes were present in the anterior chamber, trabecular meshwork, and uveal tract. An intraocular lens was present in the lens capsule with a small amount of residual cortex. The retina showed focal edema, a thin epiretinal membrane, and scattered small drusen in the posterior pole. The internal limiting membrane was intact and ganglion and nerve fiber layers of the retina were normal. Small numbers of acute and chronic inflammatory cells were found between the internal limiting membrane and posterior vitreous surface. Scattered lymphocytes were present in the pial septa of the optic nerve. Multiple sections of the globe were examined with special stains for acid-fast organisms and none were found.

The specimen from the left eyelid biopsy performed 3 months earlier (for which the patient received radiation therapy) was retrieved and showed an actinic keratosis. No acid-fast organisms were present.

E. H. Runyon as cited by Turner1 divided the nontuberculous mycobacteria into 4 groups based on their cultural characteristics and the development of pigmentation when exposed to light. Mycobacterium chelonae belongs to Runyon group IV, which is characterized by rapid growth, absence of yellow pigment and growth on MacConkey agar. Mycobacterium fortuitum and M chelonae(also known as M fortuitum complex) are the most important members of this group and are distinguished from one another by differences in the nitrate reductase test. Atypical mycobacteria of Runyon group IV usually cause mucocutaneous infection, typically after surgery or trauma. Primary skin or eye infection without a history of antecedent surgery or trauma is uncommon. Disseminated infection is rare in persons who are not immunocompromised.

Nontuberculous mycobacteria infections have been associated with several ophthalmologic procedures. Orbital and periocular infections have followed dacryocystorhinostomy and tear duct probing.3 The cornea is the most common site of ocular infection. Mycobacterial keratitis has been reported following simple outpatient office procedures,9 radial keratotomy,7 pterygium removal,14 cataract extraction,6 contact lens use,10 refractive surgery,11,13 and keratoplasty.4,6,15 The primary source of infection is seldom found, although several epidemiologic investigations have implicated contaminated surgical instruments.79

The primary source of the ocular infection in this patient was not determined. In all likelihood, however, the infection was acquired at the time of vitrectomy and involved an instrument or substance passing through the sclerotomy sites. Each of the 3 separate foci of conjunctival and scleral infection arose at sclerotomy sites and cultures taken from the vitreous effluent at the time of surgery (as part of an unrelated research project) grew 18 colonies of an acid-fast organism within 5 days. No other mycobacterial infection had been reported from this operating room. Environmental cultures were never taken. To our knowledge, this is the first report describing mycobacterial scleritis and conjunctivitis following vitrectomy.

An alternative explanation for the origin of this infection is that the patient harbored mycobacterial organisms in his conjunctiva prior to vitrectomy. Radiation therapy, and perhaps other topical therapies, could have predisposed the conjunctiva to opportunistic infection or colonization by mycobacterial organisms. Although white and quiet at the time of vitrectomy, our patient's conjunctiva, which was chronically inflamed for more than 6 months prior to surgery, cannot be discounted as the potential source of the infection.

The optimal therapy for nontuberculous mycobacterial infections is not known. Amikacin has been the single most frequently used antibiotic for atypical mycobacterial infection, but some patients fail to respond to topical therapy.5,9,10,17 Anecdotal experience with topical fluoroquinolones has been limited and the clinical impression of its effectiveness has been mixed.4,5,17 Some nontuberculous mycobacteria demonstrate in vitro resistance to ciprofloxacin.4 Topical ciprofloxacin may be more effective against M fortuitum than M chelonae.17 Animal models of atypical mycobacterial keratitis have shown that topical ciprofloxacin can effectively reduce the number of organisms and infiltrate size, but these findings are more consistently demonstrated for M fortuitum than M chelonae.1922 Animal models have also suggested that multiple topical drugs do not improve effectiveness.19 Single-agent treatment, however, may be more likely to fail because of the development of drug resistance.23,24 In one series, clarithromycin had the best in vitro sensitivity profile against nontuberculous mycobacteria.4 In vitro sensitivity testing from our patient revealed resistance to all antibiotics except kanamycin, amikacin, and clarithromycin. Systemic antibiotics were used empirically because of scleral involvement, but there has been too little experience with the use of parenteral antibiotics in this setting to draw any conclusion about effectiveness.

One of the more perplexing aspects of this case was the progressive deterioration of the cornea during therapy. The cornea was initially uninvolved and became progressively opaque at a time when cultures and biopsy specimens from the conjunctiva indicated a favorable response to antibiotic therapy. The enucleated eye showed extensive corneal stromal necrosis and chronic inflammation, and no acid-fast organisms. The mechanism of cornea injury is unclear but could have been due to mycobacterial infection before eradication. Another possibility is that continuous amikacin lavage for 3 weeks caused toxic injury to the cornea.

Although most atypical mycobacteria are regarded as having low pathogenicity, they can cause serious opportunistic infections that are difficult to control. The growth of nontuberculous mycobacteria from an intraocular culture should not be regarded as an inconsequential contaminant, particularly if more than several colonies are recovered.25

Accepted for publication July 20, 1999.

Corresponding author: Curtis E. Margo, MD, MPH, Watson Clinic, Ophthalmology, 1600 Lakeland Hills Blvd, Lakeland, FL 33805.

Turner  L Atypical mycobacterial infections in ophthalmology. Trans Am Ophthalmol Soc. 1970;68667- 729
Wallace  RJ  JrSwenson  JMSilcox  VAGood  RCTschem  JAStone  MS Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5657- 677
Link to Article
Not Available, Mycobacterium chelonei infections following eye surgery-Texas. MMWR Morb Mortal Wkly Rep. 1983;32591- 597
Ford  JGHuang  AJWPlugfelder  SCAlfonso  ECForster  RKMiller  D Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology. 1998;1051652- 1658
Link to Article
Hwang  DGBiswell  R Ciprofloxacin therapy of Mycobacterium chelonae keratitis. Am J Ophthalmol. 1993;115114- 115
Roussel  TJStern  WHGoodman  DFWhitcher  J Postoperative myobacterial endophthalmitis. Am J Ophthalmol. 1989;107403- 407
Robin  JBBeatty  RFDunn  S  et al.  Mycobacterium chelonei keratitis after radial keratotomy. Am J Ophthalmol. 1986;10272- 79
Lazar  MNemet  RBracha  RCampus  A Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1974;78530- 532
Newman  PEGoodman  RAWaring  GO  III  et al.  A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol. 1984;97344- 348
Khooshabeh  RGrange  JMYates  MDMcCartney  ACECasey  TA A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis. 1994;75377- 382
Link to Article
Brancato  RCarones  FVenturi  ECavallero  AGesu  G Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. Arch Ophthalmol. 1997;1151316- 1318
Link to Article
Bullington  RHLanier  JDFont  RL Nontuberculous mycobacterial keratitis: report of 2 cases and review of the literature. Arch Ophthalmol. 1992;110519- 524
Link to Article
Reviglio  VRodriguez  MLRicotti  GSParadello  MJuna  JDJuarez  CP Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg. 1998;14357- 360
Hsiao  CHChen  JJHuang  SCMa  HKChen  PYTsai  RJ Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol. 1998;8229- 34
Link to Article
Huang  SCSoong  HKChang  JSLiang  YS Non-tuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol. 1996;80962- 968
Link to Article
Dugel  PUHolland  GNBrown  HH  et al.  Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1988;105661- 669
He  FLuh  K Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Ophthalmology. 1998;105269- 272
Link to Article
Pavan  PRMenowsky  MMArango  JLLivington  PG Significance of positive vitreous cassette cultures. Vitreous Soc Online J [serial online]. September1999;[posted June 20, 2000]; 2(1) [11 screens]. Available at: http://www.vitreoussociety.org. Accessibility verified June 26, 2000
He  FRWang  IJ Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model. Curr Eye Res. 1998;17478- 482
Link to Article
Collins  CHUttley  AH In vitro susceptibility of mycobacteria to ciprofloxacin. J Antimicrob Chemother. 1985;16575- 580
Link to Article
Lin  RHolland  GNHelm  CJ  et al.  Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model. Am J Ophthalmol. 1994;117657- 662
Stevens  RKHolland  GNPaschal  JP  et al.  Mycobacterium fortuitum keratitis: a comparison of topical ciprofloxacin and amikacin in an animal model. Cornea. 1992;11500- 504
Link to Article
Wallace  RJ  JrBedsole  GSumter  G  et al.  Activity of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single drug therapy. Antimicrob Agents Chemother. 1990;3465- 70
Link to Article
Driscoll  MSTyring  SK Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol. 1997;36495- 6
Link to Article
Mames  RNFriedman  SMStinson  WGMargo  CE Positive vitreous cultures from eyes without signs of infectious endophthalmitis. Ophthalmic Surg Lasers. 1997;28365- 369

Figures

Place holder to copy figure label and caption
Figure 1.

Left, A 3 × 6-mm scleral defect is present in the left eye between the 2- and 4-o'clock positions just posterior to the limbus at the site of a previous vitrectomy port. The area of scleral thinning is surrounded by intensely hyperemic conjunctiva and sclera. The cornea is transparent at this time. Right, A similar but more circular area of scleral thinning is present at the second vitrectomy port site at the 10-o'clock position. No discharge is present.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Results of a left conjunctival biopsy adjacent to the area of scleral thinning shows a mixture of chronic inflammatory cells. Numerous lymphocytes are dispersed among clusters of paler-staining epithelioid cells (asterisk) (hematoxylin-eosin, original magnification × 60).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Acid-fast stain of conjunctival biopsy specimen shows an acid-fast positive rod within epithelioid histiocyte, center of photograph (Ziehl-Neelsen, original magnification × 410).

Graphic Jump Location

Tables

References

Turner  L Atypical mycobacterial infections in ophthalmology. Trans Am Ophthalmol Soc. 1970;68667- 729
Wallace  RJ  JrSwenson  JMSilcox  VAGood  RCTschem  JAStone  MS Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5657- 677
Link to Article
Not Available, Mycobacterium chelonei infections following eye surgery-Texas. MMWR Morb Mortal Wkly Rep. 1983;32591- 597
Ford  JGHuang  AJWPlugfelder  SCAlfonso  ECForster  RKMiller  D Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology. 1998;1051652- 1658
Link to Article
Hwang  DGBiswell  R Ciprofloxacin therapy of Mycobacterium chelonae keratitis. Am J Ophthalmol. 1993;115114- 115
Roussel  TJStern  WHGoodman  DFWhitcher  J Postoperative myobacterial endophthalmitis. Am J Ophthalmol. 1989;107403- 407
Robin  JBBeatty  RFDunn  S  et al.  Mycobacterium chelonei keratitis after radial keratotomy. Am J Ophthalmol. 1986;10272- 79
Lazar  MNemet  RBracha  RCampus  A Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1974;78530- 532
Newman  PEGoodman  RAWaring  GO  III  et al.  A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol. 1984;97344- 348
Khooshabeh  RGrange  JMYates  MDMcCartney  ACECasey  TA A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis. 1994;75377- 382
Link to Article
Brancato  RCarones  FVenturi  ECavallero  AGesu  G Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. Arch Ophthalmol. 1997;1151316- 1318
Link to Article
Bullington  RHLanier  JDFont  RL Nontuberculous mycobacterial keratitis: report of 2 cases and review of the literature. Arch Ophthalmol. 1992;110519- 524
Link to Article
Reviglio  VRodriguez  MLRicotti  GSParadello  MJuna  JDJuarez  CP Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg. 1998;14357- 360
Hsiao  CHChen  JJHuang  SCMa  HKChen  PYTsai  RJ Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol. 1998;8229- 34
Link to Article
Huang  SCSoong  HKChang  JSLiang  YS Non-tuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol. 1996;80962- 968
Link to Article
Dugel  PUHolland  GNBrown  HH  et al.  Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1988;105661- 669
He  FLuh  K Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Ophthalmology. 1998;105269- 272
Link to Article
Pavan  PRMenowsky  MMArango  JLLivington  PG Significance of positive vitreous cassette cultures. Vitreous Soc Online J [serial online]. September1999;[posted June 20, 2000]; 2(1) [11 screens]. Available at: http://www.vitreoussociety.org. Accessibility verified June 26, 2000
He  FRWang  IJ Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model. Curr Eye Res. 1998;17478- 482
Link to Article
Collins  CHUttley  AH In vitro susceptibility of mycobacteria to ciprofloxacin. J Antimicrob Chemother. 1985;16575- 580
Link to Article
Lin  RHolland  GNHelm  CJ  et al.  Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model. Am J Ophthalmol. 1994;117657- 662
Stevens  RKHolland  GNPaschal  JP  et al.  Mycobacterium fortuitum keratitis: a comparison of topical ciprofloxacin and amikacin in an animal model. Cornea. 1992;11500- 504
Link to Article
Wallace  RJ  JrBedsole  GSumter  G  et al.  Activity of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single drug therapy. Antimicrob Agents Chemother. 1990;3465- 70
Link to Article
Driscoll  MSTyring  SK Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol. 1997;36495- 6
Link to Article
Mames  RNFriedman  SMStinson  WGMargo  CE Positive vitreous cultures from eyes without signs of infectious endophthalmitis. Ophthalmic Surg Lasers. 1997;28365- 369

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles